2Sudbrak R, Brown J, Dobson-Stone C, et al. Hailey-Hailey disease is cansed by mutations in ATP2C1 encoding a novel Ca (2+) pump[J]. Hum Mol Genet, 2000, 9(7): 1131-1140.
3Chao SC, Tsai YM, Yang MH. Mutation analysis of ATP2C1 gene in Taiwan Residents patients with Hailey-Hailey disease [J]. Br J Dermatol, 2002, 146(4): 595-600.
4Li H, Sun XK, Zhu XJ. Four novel mutations in ATP2C1 found in Chinese patients with Hailey-Hailey disease [J]. Br J Dermatol, 2003, 149(3): 471-474.
5Sakuntabhai A, Ruiz-Perez V, Carter S, et al. Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease[J]. Nature Genet, 1999, 21(3): 271-277.
4Rocha Paris F, Fidalgo A, Baptista J, et al. Topical tacrolimus in Halley-Halley disease[J], lnt J Tissue React, 2005, 27(4): 151-154.
5Mashiko M, Akiyama M, Tsuji-Abe Y, et al. Bacterial infectioninduced generalized Hailey-Hailey disease successfully treated by etretinate[J]. Clin Exp Dermatol, 2006, 31(1): 57-59.
6Sudbrak R, Brown J, DobsonStone C, et al. Hailey-Halley disease is cansed by mutations in ATP2C1 encoding a novel Ca2+ pump. Hum Mol Genet 2000;9(7) : 1151-1140.
7Hu Z, Bonifas JM, Beech J, et al. Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nature Genetics 2000;24(1) :61-65.
8Xu Z, Zhang LX, Xiao YY, et al. A Case of HaileyHalley Disease in an Infant with a New ATP2C1 Gene Mutation. Pediatric Dermatology 2010; 1 : 88.
9Lapiere JC, Hirsh A, Gordon KB. Botulinum toxin type A for the treatment of axillary Halley-Hailey disease. Dermtol Surg 2000; 26(4):371-374.
10Sand C, Thomsen HK. Topical tacrolimus ointment is an effective therapy for Hailey-Hailey disease. Arch Dermatol 2003; 139 (11):14051406.
